CHMFL-FLT3-122 T27011
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting
CAS nr:
1839150-56-9
Purity:
98%
Molecular Weight:
471,57
SMILES:
CN(CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O)C
Formula:
C26H29N7O2
Pathway:
Target:
